UPDATE 2-Protein Design rallies on Roche deal, then fizzles
447334
Shares of Protein Design Labs Inc. (PDLI.O: Quote, Profile, Research) rallied but then fizzled on Thursday after initial enthusiasm waned for the US biotechnology
507775
By Tricia Bishop, The Baltimore Sun  Dec. 14--One of MedImmune Inc.'s major shareholders is urging the state's flagship biotech to put itself up for sale, suggesting management hasn't made the most from its assets, which include four products on the market and about 40 in the pipeline.
529990
Swiss pharmaceutical giant Roche has posted a record full year net profit of 9.2 billion Swiss francs (7.4 billion dollars, 5.7 billion euros) in 2006, but its shares fell in morning trading as investors opted for profit-taking.
301149
Cambridge Antibody Technology&#39;s (Nasdaq: CATG) legal victory over Abbott Laboratories (NYSE: ABT) shows that a biotech David can triumph over a pharmaceutical Goliath.
92125
It and Roche would be a good combination, but for now, this hostile takeover bid is stalled.
477072
MARSEILLE, FRANCE - Netino SARL sees a bright future for outsourcing in drug discovery: The 2-year-old company just landed a 10-year contract to handle the bioinformatics activities of a major French pharmaceutical company.
145474
Looking over all the biotech stock stories I covered in 2004, I&#39;m pleased to report that I was right more than wrong. My &quot;win&quot; column does veer in the bearish direction, which is not ideal (I&#39;d prefer more
395582
J&J and Schering revise their agreement over anti-TNF compounds.
163914
STOCKHOLM/ZURICH  - Some seasonal influenza viruses are resistant to Roche Holding AG's Tamiflu, a study showed, but Roche said no doubts had been raised about the drug's power to combat any deadly bird flu pandemic.
377721
Faced with the threat of generic competition, the company focuses its efforts on a new drug.
226791
A court ruling upholding the  patent on blockbuster blood-thinning drug Plavix has reignited  talk France&#39;s Sanofi-Aventis  will bid for its smaller  U.S. partner Bristol-Myers Squibb Co. .
684683
Swiss pharmaceutical giant Roche has reached a merger agreement with US health diagnostics specialist Ventana Medical Systems for 3.4 billion dollars (2.36 billion euros), six months after launching its takeover bid, Roche announced Tuesday.
147168
The approval of a new drug is a long-term opportunity.
455403
The biopharma announces a dramatic shift following the failure of its lead drug.
462762
Biopure Corp. is running out of money -- again. Recent regulatory filings, including one yesterday, show the Cambridge blood-substitute developer seeking the financial flexibility it says it will need to keep operating after January. That's when it expects to use up the $7 million it raised through a stock sale in September.
409761
Genzyme shows some sparkle at investors' conference.
611830
Scientists pinpoint a protein they believe holds the key to hearing, and maybe new treatments for deafness.